Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Total Non-Current Liabilities (2016 - 2021)

OptimizeRx (OPRX) has disclosed Total Non-Current Liabilities for 12 consecutive years, with $260614.0 as the latest value for Q3 2021.

  • Quarterly Total Non-Current Liabilities fell 26.92% to $260614.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $260614.0 through Sep 2021, down 26.92% year-over-year, with the annual reading at $325533.0 for FY2020, 94.26% down from the prior year.
  • Total Non-Current Liabilities hit $260614.0 in Q3 2021 for OptimizeRx, down from $282934.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $5.7 million in Q4 2019 to a low of $260614.0 in Q3 2021.
  • Historically, Total Non-Current Liabilities has averaged $1.6 million across 5 years, with a median of $1.6 million in 2017.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 512.12% in 2017 and later plummeted 94.26% in 2020.
  • Year by year, Total Non-Current Liabilities stood at $2.3 million in 2017, then grew by 4.8% to $2.4 million in 2018, then soared by 139.69% to $5.7 million in 2019, then tumbled by 94.26% to $325533.0 in 2020, then decreased by 19.94% to $260614.0 in 2021.
  • Business Quant data shows Total Non-Current Liabilities for OPRX at $260614.0 in Q3 2021, $282934.0 in Q2 2021, and $305039.0 in Q1 2021.